Literature DB >> 12673693

Determination of a minimal region of loss of heterozygosity on chromosome 18q21.33 in osteosarcoma.

Teresa L Johnson-Pais1, Maggie J Nellissery, Donald G Ammerman, Dharmini Pathmanathan, Pardeep Bhatia, Carolyn L Buller, Robin J Leach, Marc F Hansen.   

Abstract

Previous analysis of tumor-specific constitutional LOH had identified a putative tumor-suppressor gene (LOH18CR) active in osteosarcoma tumorigenesis, which mapped to a subregion of chromosome 18q linked to both familial Paget's disease and FEO. Using 9 new polymorphic loci within the previous minimal region of LOH, we have reduced the minimal region of LOH in osteosarcoma tumors to localize the LOH18CR locus to the distal end of chromosome 18q21.33. This new region is approximately 500 kb and contains at least 7 known genes; however, it excludes 2 previous candidate genes: TNFRSF11A (RANK) and BCL2. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12673693     DOI: 10.1002/ijc.11070

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Suppression of survival signalling pathways by the phosphatase PHLPP.

Authors:  Audrey K O'Neill; Matthew J Niederst; Alexandra C Newton
Journal:  FEBS J       Date:  2012-03-16       Impact factor: 5.542

2.  Molecular biology and therapeutics in musculoskeletal oncology.

Authors:  Theresa A Guise; Regis O'Keefe; R Lor Randall; Richard M Terek
Journal:  J Bone Joint Surg Am       Date:  2009-03-01       Impact factor: 5.284

Review 3.  Binding of pro-prion to filamin A: by design or an unfortunate blunder.

Authors:  C Li; W Xin; M-S Sy
Journal:  Oncogene       Date:  2010-08-09       Impact factor: 9.867

Review 4.  PHLPPing through history: a decade in the life of PHLPP phosphatases.

Authors:  Agnieszka T Grzechnik; Alexandra C Newton
Journal:  Biochem Soc Trans       Date:  2016-12-15       Impact factor: 5.407

5.  A summary of the osteosarcoma banking efforts: a report from the Children's Oncology Group and the QuadW Foundation.

Authors:  Jason Glover; Mark Krailo; Tanya Tello; Neyssa Marina; Katherine Janeway; Don Barkauskas; Timothy M Fan; Richard Gorlick; Chand Khanna
Journal:  Pediatr Blood Cancer       Date:  2014-12-08       Impact factor: 3.167

Review 6.  The impact of phosphatases on proliferative and survival signaling in cancer.

Authors:  Goutham Narla; Jaya Sangodkar; Christopher B Ryder
Journal:  Cell Mol Life Sci       Date:  2018-05-03       Impact factor: 9.261

Review 7.  PHLiPPing the switch on Akt and protein kinase C signaling.

Authors:  John Brognard; Alexandra C Newton
Journal:  Trends Endocrinol Metab       Date:  2008-05-27       Impact factor: 12.015

8.  The genetics of osteosarcoma.

Authors:  Jeff W Martin; Jeremy A Squire; Maria Zielenska
Journal:  Sarcoma       Date:  2012-05-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.